Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cornelis L Verweij
The Interferon Type I Signature Towards Prediction of Non-Response to Rituximab in Rheumatoid Arthritis Patients
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Moving Towards Personalized Medicine in Rheumatoid Arthritis
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Related publications
Importance of Correlation Between Gene Expression Levels: Application to the Type I Interferon Signature in Rheumatoid Arthritis
PLoS ONE
Multidisciplinary
Type I Interferon Response Gene Expression in Established Rheumatoid Arthritis Is Not Associated With Clinical Parameters
Arthritis Research & Therapy
Variants of Genes Implicated in Type 1 Interferon Pathway and B-Cell Activation Modulate the EULAR Response to Rituximab at 24 Weeks in Rheumatoid Arthritis
RMD Open
Rheumatology
Allergy
Immunology
Rituximab Therapy in Greek Patients With Rheumatoid Arthritis
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Safety of Rituximab in Rheumatoid Arthritis
Reumatismo
Rheumatology
Non-Response to Rituximab Therapy in Rheumatoid Arthritis Is Associated With Incomplete Disruption of the B Cell Receptor Repertoire
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
Journal of Rheumatology
Rheumatology
Allergy
Immunology
FRI0224 Rituximab Selectively Reduces Igg4 Levels in Rheumatoid Arthritis Patients
NK Cell Count as Predictor of Clinical Response in Patients With Rheumatoid Arthritis Treated With Rituximab
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
